Jenna Bergerson

ORCID: 0000-0001-9122-4998
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Immunodeficiency and Autoimmune Disorders
  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology
  • Blood disorders and treatments
  • SARS-CoV-2 and COVID-19 Research
  • Diabetes and associated disorders
  • Chronic Lymphocytic Leukemia Research
  • Adenosine and Purinergic Signaling
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • Viral Infections and Immunology Research
  • Genetic factors in colorectal cancer
  • interferon and immune responses
  • Cytomegalovirus and herpesvirus research
  • CAR-T cell therapy research
  • RNA regulation and disease
  • Complement system in diseases
  • Genomics and Rare Diseases
  • Parvovirus B19 Infection Studies
  • Polyomavirus and related diseases
  • COVID-19 Clinical Research Studies
  • Platelet Disorders and Treatments
  • Food Allergy and Anaphylaxis Research
  • Cancer Immunotherapy and Biomarkers
  • Cytokine Signaling Pathways and Interactions
  • Immune responses and vaccinations

National Institute of Allergy and Infectious Diseases
2018-2025

National Institutes of Health
2018-2025

Immune Deficiency Foundation
2021-2024

Office of Extramural Research
2019-2022

Flinders Medical Centre
2022

University of Exeter
2022

Children's Hospital of Pittsburgh
2022

Organogenesis (United States)
2019

Lurie Children's Hospital
2016-2018

Northwestern University
2017-2018

The Human Phenotype Ontology (HPO)—a standardized vocabulary of phenotypic abnormalities associated with 7000+ diseases—is used by thousands researchers, clinicians, informaticians and electronic health record systems around the world. Its detailed descriptions clinical computable disease definitions have made HPO de facto standard for deep phenotyping in field rare disease. HPO's interoperability other ontologies has enabled it to be improve diagnostic accuracy incorporating model organism...

10.1093/nar/gky1105 article EN cc-by Nucleic Acids Research 2018-10-25

X-linked immunodeficiency with magnesium defect, EBV infection, and neoplasia (XMEN) disease are caused by deficiency of the transporter 1 (MAGT1) gene. We studied 23 patients XMEN, 8 whom were naive. observed lymphadenopathy (LAD), cytopenias, liver disease, cavum septum pellucidum (CSP), increased CD4-CD8-B220-TCRαβ+ T cells (αβDNTs), in addition to previously described features an inverted CD4/CD8 ratio, CD4+ lymphocytopenia, B cells, dysgammaglobulinemia, decreased expression natural...

10.1172/jci131116 article EN Journal of Clinical Investigation 2019-11-12

Abstract The study of early T-cell development in humans is challenging because limited availability thymic samples and the limitations vitro differentiation assays. We used an artificial organoid (ATO) platform generated by aggregating a DLL4-expressing stromal cell line (MS5-hDLL4) with CD34+ cells isolated from bone marrow or mobilized peripheral blood to patients carrying hematopoietic intrinsic defects that cause lymphopenia. found AK2 deficiency associated decreased viability block...

10.1182/bloodadvances.2020001730 article EN cc-by-nc-nd Blood Advances 2020-06-17

The deficiency of adenosine deaminase 2 (DADA2) is an autosomal recessively inherited disease that has undergone extensive phenotypic expansion since being first described in patients with fevers, recurrent strokes, livedo racemosa, and polyarteritis nodosa 2014. It now recognized may develop multisystem spans multiple medical subspecialties. Here, we describe the findings from a large single center longitudinal cohort 60 patients, broad presentation, as well highlight cohort’s experience...

10.3389/fimmu.2021.811473 article EN cc-by Frontiers in Immunology 2022-01-10

Recombination activating genes ( RAGs ) are tightly regulated during lymphoid differentiation, and their mutations cause a spectrum of severe immunological disorders. Hematopoietic stem progenitor cell (HSPC) transplantation is the treatment choice but limited by donor availability toxicity. To overcome these issues, we developed gene editing strategies targeting corrective sequence into human RAG1 homology-directed repair (HDR) validated them tailored two-dimensional, three-dimensional, in...

10.1126/scitranslmed.adh8162 article EN Science Translational Medicine 2024-02-07
Marita Bosticardo Kerry Dobbs Ottavia M. Delmonte Andrew J. Martins Francesca Pala and 95 more Tomoki Kawai Heather Kenney Gloria Magro Lindsey B. Rosen Yasuhiro Yamazaki Hsin‐Hui Yu Enrica Calzoni Yu Nee Lee Can Liu Jennifer Stoddard Julie E. Niemela Danielle Fink Riccardo Castagnoli Meredith Ramba Aristine Cheng Deanna Riley Vasileios Oikonomou Elana Shaw Brahim Belaid Sevgi Keleş Waleed Al‐Herz Caterina Cancrini Cristina Cifaldi Safa Barış Svetlana O. Sharapova Catharina Schuetz Andrew R. Gennery Alexandra F. Freeman Raz Somech Sharon Choo Silvia Giliani Tayfun Güngör Daniel Drozdov Isabelle Meyts Despina Moshous Bénédicte Neven Roshini S. Abraham Aisha Elmarsafy Maria Kanariou Alejandra King Francesco Licciardi Mario Ernesto Cruz-Muñoz G. Olivieri M. Cecilia Poli Mehdi Adeli Mattia Algeri Fayhan Alroqi Paul Bastard Jenna Bergerson Claire Booth Ana Brett Siobhan O. Burns Manish J. Butte Nurcicek Padem Maite de la Morena Ghassan Dbaibo Suk See De Ravin Dimana Dimitrova Réda Djidjik Mayra de Barros Dorna Cullen M. Dutmer Reem Elfeky Fabio Facchetti Ramsay Fuleihan R S Geha Luis Ignacio González‐Granado Liis Haljasmägi Hanadys Ale Anthony Hayward Anna Hilfanova Winnie Ip Blanka Kaplan Neena Kapoor Elif Karakoç-Aydıner Jaanika Kärner Michael D. Keller Blachy J. Dávila Saldaña Ayça Kıykım Taco W. Kuijpers Elena Kuznetsova Elena A. Latysheva Jennifer W. Leiding Franco Locatelli Guisela Alva‐Lozada Christine McCusker Fatih Çelmeli Megan Morsheimer Ahmet Özen Nima Parvaneh Srdjan Pašić Alessandro Plebani Kahn Preece Susan E. Prockop Inga Sakovich Elena E. Starkova

Human recombination-activating gene (RAG) deficiency can manifest with distinct clinical and immunological phenotypes. By applying a multiomics approach to large group of RAG-mutated patients, we aimed at characterizing the immunopathology associated each phenotype. Although defective T B cell development is common all phenotypes, patients hypomorphic RAG variants generate cells signatures immune dysregulation produce autoantibodies broad range self-antigens, including type I interferons....

10.1126/sciimmunol.adq1697 article EN Science Immunology 2025-01-10
Kathleen Baysac Guangping Sun Hiroto Nakano Elizabeth Schmitz Anthony Cruz and 91 more Charles G. Fisher Alexis C. Bailey Emily M. Mace Joshua D. Milner Michael J. Ombrello Jordan K. Abbott Juan Carlos Aldave Becerra Eric J. Allenspach Kristian Assing T. Prescott Atkinson Umair Ahmed Bargir Sarah K. Baxter Jenna Bergerson Ranjan Bista Stéphane Blanche Lenore M. Buckley Manish J. Butte Benjamin Carcamo Chandrakala Shanmukhaiah Karin Chen Sheva K. Chervinskiy Iván K. Chinn Hey Chong Kara E. Coffey Andrew P. Copland Edward W. Cowen Guilhem Cros Jean Jacques De Bruycker M. Teresa de la Morena M S Ehlayel Lisa Forbes Satter Erwin W. Gelfand Olivier Gilliaux Sarah C. Glover Mark Gorman Thomas A. Griffin Bodo Grimbacher Alejandro A. Gru Élie Haddad Jérôme Hadjadj Joud Hajjar Fabian Hauck Timo Hautala Steven M. Holland Elena W.Y. Hsieh Florence Ida Hsu Emmanuel Jacquemin Ankur Kumar Jindal Stacy A. Kahn Michael D. Keller Roger H. Kobayashi Christa Krupski Allyson Larkin Monica G. Lawrence Manisha Madkaikar Marion Malphettes Timi Martelius Mehek Mehta Dean D. Metcalfe Isabelle Meyts Naveen Nannapaneni Javier Gonzalo Ocejo Vinyals Kenneth N. Olivier Amanda K. Ombrello Jordan S. Orange Nathan Rabinovitch C. Rauscher Ann Redfern Paul R. Reynolds Frédéric Rieux‐Laucat Elizabeth Secord Filiz O. Seeborg Mikko Seppänen Irini Sereti Daniel S. Shin Junghee J. Shin Scott B. Snapper Deepti Suri Sirikarn Tangcheewinsirikul Akaluck Thatayatikom Troy R. Torgerson Fabien Touzot Gülbû Uzel Markku Varjosalo Dewton F.P. Vasconcelos Horst von Bernuth Thomas J. Walsh Jolán E. Walter Brant R. Ward Helmut Wittkowski Christian Wysocki

10.1016/j.jaci.2023.08.036 article EN Journal of Allergy and Clinical Immunology 2023-09-26

We describe a previously-unappreciated role for Bruton's tyrosine kinase (BTK) in fungal immune surveillance against aspergillosis, an unforeseen complication of BTK inhibitors (BTKi) used treating B-cell lymphoid malignancies. studied BTK-dependent responses neutrophils from diverse populations, including healthy donors, BTKi-treated patients, and X-linked agammaglobulinemia patients. Upon exposure, was activated human TLR2-, Dectin-1-, FcγR-dependent manner, triggering the oxidative burst....

10.1172/jci176142 article EN cc-by Journal of Clinical Investigation 2024-05-02

Patients with the monogenic immune dysregulatory syndrome autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED), which is caused by loss-of-function mutations in regulator ( AIRE ) gene, uniformly carry neutralizing autoantibodies directed against type-I interferons (IFNs) and many develop pneumonitis, both of place them at high risk for life-threatening COVID-19 pneumonia. Bamlanivimab etesevimab are monoclonal antibodies (mAbs) that target SARS-CoV-2 spike protein block...

10.3389/fimmu.2021.720205 article EN cc-by Frontiers in Immunology 2021-08-24

Summary Background Non‐cirrhotic portal hypertension (NCPH) is a spectrum of liver diseases, including porto‐sinusoidal vascular disorder, with (PH) in the absence cirrhosis. The natural history and diagnostic approach to NCPH are not well understood. Aim We aimed evaluate disease progression outcomes NCPH. Methods Patients or at risk for were enrolled single centre prospective study; two groups formed based on presence specific features PH, such as varices, collaterals, hypertensive...

10.1111/apt.17987 article EN Alimentary Pharmacology & Therapeutics 2024-04-17
Coming Soon ...